Goodwin advised Teva Pharmaceuticals International GmbH., a subsidiary of Teva Pharmaceutical Industries Ltd., on its global license agreement with Alder BioPharmaceuticals. The agreement validates Teva’s IP…
Teva’s $200 Million Global License Agreement With Alder BioPharmaceuticals®
![](https://globallegalchronicle.com/wp-content/uploads/2018/01/94f0221a90.jpeg)